Globe Life (GL) raised its full year 2026 earnings guidance after reporting Q1 results that showed higher net operating income per share and strong health premium revenues, giving investors fresh information on the insurer’s current momentum.

Globe Life’s raised 2026 guidance comes as the share price sits at US$152.56, with a 30-day share price return of 10.94% and a 1-year total shareholder return of 25.13%. This suggests momentum has been building around earnings, buybacks, and dividend actions.

If this kind of insurance earnings story has your attention, it can be a good moment to see what else is out there and uncover 19 top founder-led companies

With earnings guidance moving higher, a long track record of buybacks and the shares still trading below the average analyst price target, the key question is whether Globe Life is still mispriced or if the market is already factoring in future growth.

Most Popular Narrative: 11.4% Undervalued

Globe Life’s most followed narrative puts fair value at $172.10 per share versus the last close of $152.56, framing the current price as a discount to long term earnings power anchored by steady growth and capital returns.

The planned establishment of a Bermuda reinsurance affiliate is expected to significantly increase parent company free cash flow and financial flexibility by 2027 and beyond, providing greater capacity for share repurchases and/or strategic investments, positively impacting earnings per share.

Want to see what is driving that valuation gap? The narrative leans on measured revenue gains, slightly higher margins, and ongoing shrinkage in the share count. Curious how those pieces fit together into $172.10 per share and an 11.4% discount based on a 6.98% discount rate and a future earnings multiple below sector levels?

Result: Fair Value of $172.10 (UNDERVALUED)

However, this hinges on execution. Globe Life’s agent heavy model and ongoing regulatory and investigation risks are both capable of compressing growth assumptions and valuation multiples.

Next Steps

With mixed sentiment around guidance, capital returns, and risk, it makes sense to check the numbers yourself and decide where you stand. You can quickly weigh both sides by reviewing the 4 key rewards and 1 important warning sign

Looking for more investment ideas?

If Globe Life is on your radar, do not stop there. Broaden your watchlist with other ideas that could suit your style before the market moves on.

• Target potential mispricings by scanning 56 high quality undervalued stocks, which combine solid fundamentals with room for market expectations to catch up.
• Build an income focused watchlist by checking out 13 dividend fortresses, which aim to pair higher yields with balance sheet support.
• Prioritise resilience with 72 resilient stocks with low risk scores, which show lower overall risk scores and may help smooth out the bumpier parts of your portfolio.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.